FI841649A - Biologiskt aktiva polypeptider. - Google Patents

Biologiskt aktiva polypeptider. Download PDF

Info

Publication number
FI841649A
FI841649A FI841649A FI841649A FI841649A FI 841649 A FI841649 A FI 841649A FI 841649 A FI841649 A FI 841649A FI 841649 A FI841649 A FI 841649A FI 841649 A FI841649 A FI 841649A
Authority
FI
Finland
Prior art keywords
polypeptider
biologically active
biologically
active
active polypeptider
Prior art date
Application number
FI841649A
Other languages
English (en)
Other versions
FI841649A0 (fi
FI81365B (fi
FI81365C (fi
Inventor
George Joseph Todaro
Original Assignee
George Joseph Todaro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Joseph Todaro filed Critical George Joseph Todaro
Publication of FI841649A0 publication Critical patent/FI841649A0/fi
Publication of FI841649A publication Critical patent/FI841649A/fi
Priority to FI883765A priority Critical patent/FI81497C/fi
Publication of FI81365B publication Critical patent/FI81365B/fi
Application granted granted Critical
Publication of FI81365C publication Critical patent/FI81365C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI841649A 1983-05-09 1984-04-26 Foerfarande foer framstaellning av biologiskt aktiva polypeptider. FI81365C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI883765A FI81497C (fi) 1983-05-09 1988-08-12 Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49275183A 1983-05-09 1983-05-09
US49275183 1983-05-09
US59813684A 1984-04-12 1984-04-12
US59813684 1984-04-12

Publications (4)

Publication Number Publication Date
FI841649A0 FI841649A0 (fi) 1984-04-26
FI841649A true FI841649A (fi) 1984-11-10
FI81365B FI81365B (fi) 1990-06-29
FI81365C FI81365C (fi) 1990-10-10

Family

ID=27050855

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841649A FI81365C (fi) 1983-05-09 1984-04-26 Foerfarande foer framstaellning av biologiskt aktiva polypeptider.

Country Status (14)

Country Link
EP (1) EP0132021B1 (fi)
JP (1) JPH07173193A (fi)
AU (1) AU575049B2 (fi)
CA (2) CA1341508C (fi)
DE (1) DE3485219D1 (fi)
DK (1) DK227384A (fi)
ES (1) ES532286A0 (fi)
FI (1) FI81365C (fi)
GR (1) GR82078B (fi)
IE (1) IE57724B1 (fi)
IL (1) IL71702A (fi)
NO (1) NO169348C (fi)
NZ (1) NZ207983A (fi)
PT (1) PT78571B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE85080T1 (de) * 1984-02-17 1993-02-15 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
AU5249786A (en) * 1985-01-29 1986-08-07 Oncogen Wound healing compositions
US4686283A (en) * 1985-04-16 1987-08-11 Syntex (U.S.A.) Inc. Analogs of transforming and epidermal growth factor fragments for therapy and diagnosis
NZ222168A (en) * 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US4931548A (en) * 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
AU1539188A (en) * 1987-05-04 1988-11-10 Bristol-Myers Squibb Company TGF-B2 and novel compositions having anti-neoplastic activity
AU6870791A (en) * 1989-10-18 1991-05-16 Creative Biomolecules, Inc. Biosynthetic constructs of tgf-beta
US6040431A (en) 1995-06-07 2000-03-21 Stryker Corporation Single chain analogs of the TGF-β superfamily (morphons)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6058960B2 (ja) * 1978-10-09 1985-12-23 サントリー株式会社 ウィルスの検出，定量剤
EP0105014B1 (en) * 1982-09-24 1992-05-20 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Repair of tissue in animals

Also Published As

Publication number Publication date
NO169348C (no) 1992-06-10
JPH07173193A (ja) 1995-07-11
PT78571B (en) 1986-06-26
FI841649A0 (fi) 1984-04-26
DK227384D0 (da) 1984-05-08
ES8600518A1 (es) 1985-09-16
NO169348B (no) 1992-03-02
PT78571A (en) 1984-06-01
DK227384A (da) 1984-11-10
DE3485219D1 (de) 1991-12-05
IE840999L (en) 1984-11-09
EP0132021A1 (en) 1985-01-23
EP0132021B1 (en) 1991-10-30
AU575049B2 (en) 1988-07-21
GR82078B (fi) 1984-12-13
CA1341508C (en) 2006-06-13
CA1341535C (en) 2007-07-24
IE57724B1 (en) 1993-03-24
NZ207983A (en) 1991-09-25
FI81365B (fi) 1990-06-29
FI81365C (fi) 1990-10-10
IL71702A0 (en) 1984-07-31
NO841827L (no) 1984-11-12
AU2751384A (en) 1984-11-15
IL71702A (en) 1988-01-31
ES532286A0 (es) 1985-09-16

Similar Documents

Publication Publication Date Title
FI843786A0 (fi) I oeppetlaege laosbar dragkoppling.
FI833312A (fi) I en uppslamningspump anvaendbar mekanisk taetning.
FI844107L (fi) Reversibelt klammermatarsko- och lucksystem foer magasinet i slagverktyg foer klamrar.
FI850424A0 (fi) Avlopp foer oeverfloede i en cyklonseparator.
FI843961L (fi) Inkapslingsshellac foer aktiva ingredienser i tuggummi.
FI875217A0 (fi) Aktivt pansar.
FI844513A0 (fi) Korrigeringskrets foer rasterdistorsion i en tv-mottagare.
FI841649A (fi) Biologiskt aktiva polypeptider.
FI832962A (fi) Pulsbredd-pulshoejd-multiplikator i en statisk kwh-maetare.
FI831634L (fi) Vaermestabileringssystem foer en inloppslaoda i en pappersmaskin.
IT1212790B (it) Peptidi biologicamente attivi.
FI843839L (fi) Avvattningselement foer vaotpartiet i en pappersmaskin.
FI840841A (fi) Taetningsanordning foer kilpartiet i avvattningsmaskiner.
FI832961A (fi) Kopplingsarrangemang i en statisk kwh- maetare.
FI831577L (fi) Slutet pressparti i pappersmaskin.
FI883254A (fi) Cytostatiskt aktiva antracyklinderivat.
IT1214444B (it) Peptidi biologicamente attivi.
FI843433A (fi) Kodstyrningssystem i en terminalanlaeggning.
FI844449A0 (fi) Styrkrets foer signalvaegen i en dataterminal.
FI843038A0 (fi) Fasaotskiljare foer en tvaofasblandning i ringstroemmar.
FI883253A (fi) Cytostatiskt aktiva antracyklinderivat.
IT8123032A0 (it) Idrazinocefem derivato biologicamente attivo.
ATE22225T1 (de) Implantat.
ATE82863T1 (de) Implantationsmaterialien.
IT8120791A0 (it) "2-benzilossimorfoline biologicamente attive".

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: TODARO, GEORGE JOSEPH